Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07165938 · ClinicalTrials.gov registry record
Genetics of Neonatal Encephalopathy and Related Disorders
A clinical trial of Neonatal Encephalopathy and Hypoxic Ischaemic Encephalopathy (HIE), sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT07165938 is a study of Neonatal Encephalopathy and Hypoxic Ischaemic Encephalopathy (HIE) that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 300 participants, above the 87-participant average among 6 other Neonatal Encephalopathy trials with a reported enrollment target (245% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07165938, a study of Neonatal Encephalopathy and Hypoxic Ischaemic Encephalopathy (HIE), is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals with a history of NE.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-02-04 |
| Est. Completion | 2035-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07165938
The ClinicalTrials.gov registry entry for NCT07165938 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 87-participant average among 6 other Neonatal Encephalopathy trials with a reported enrollment target (245% higher). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Neonatal Encephalopathy appearing as the primary indexed condition, and to 0 interventions.
NCT07165938 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07165938 about?
NCT07165938 is a clinical study titled "Genetics of Neonatal Encephalopathy and Related Disorders". Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals w...
What is the current status of trial NCT07165938?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2026-02-04. Estimated completion is 2035-09.
What conditions does trial NCT07165938 study?
This clinical trial studies the following conditions: Neonatal Encephalopathy, Hypoxic Ischaemic Encephalopathy (HIE).
Who is sponsoring clinical trial NCT07165938?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07165938 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Encephalopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Healthy Little Eyes
RECRUITING
-
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
RECRUITING · Phase 2
-
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
RECRUITING
-
Transcutaneous Carbon Dioxide Monitoring in Neonates Receiving Therapeutic Hypothermia for Neonatal Encephalopathy
ACTIVE NOT RECRUITING
-
The Impact of Holding on Stress and Bonding in Mother-Infant Pairs During Therapeutic Hypothermia
COMPLETED · NA
Explore more on PlainTrial
Neonatal Encephalopathy
All registered trials for this condition
Hypoxic Ischaemic Encephalopathy (HIE)
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.